Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs
Mesoblast develops allogeneic products based on its proprietary remestemcel-L and rexlemestrocel-L mesenchymal lineage stromal and precursor cell platform technologies. Its allogeneic cellular ...
Regenerative Medicine Breakthrough: New Method Creates 854x More Mitochondria
Scientists created a stem cell-based method to produce high-quality mitochondria at scale, enabling effective treatments for ...
C&EN15d
Comprehensive Comparison of Extracellular Vesicles Derived from Mesenchymal Stem Cells Cultured with Fetal Bovine Serum and Human Platelet Lysate
Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing 210009, China ...
Finanznachrichten21d
EQT to acquire Crown Castle's Small Cells Solutions business
Crown Castle's Small Cells Solutions business builds and operates small cells nationwide, serving mobile densification needs for cellular carriers Transaction highlights EQT's active ownership ...
Mena FN21d
EQT To Acquire Crown Castle's Small Cells Solutions Business
Crown Castle's Small Cells Solutions business is a leading builder and operator of digital infrastructure, specializing in the deployment of small cell networks that enhance essential wireless ...